AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 22727992 — intervention group
Group type: EXPERIMENTAL
Intervention: Duration of diabetes mellitus (DM) and glycated hemoglobin (HbA1c) levels
Number of subjects: 60
Study 20808337 — intervention group
Group type: EXPERIMENTAL
Intervention: 12-week intervention promoting healthier school food and changes in the school dining environment
Number of subjects: 146
Study 20808337 — intervention group
Group type: COMPARATOR
Intervention: 12-week wait-listed control group
Number of subjects: 146
Study 18195160 — intervention group
Group type: EXPERIMENTAL
Intervention: Eplerenone
Number of subjects: 16
Study 18195160 — intervention group
Group type: COMPARATOR
Intervention: Atenolol
Number of subjects: 16
Study 18195160 — intervention group
Group type: COMPARATOR
Intervention: Both Eplerenone and Atenolol
Number of subjects: 16
Study 15538568 — intervention group
Group type: EXPERIMENTAL
Intervention: CEOP/IMVP-Dexa regimen (cyclophosphamide, epirubicin, vincristine, and prednisone/ifosfamide with systemic mesna, methotrexate, etoposide, and dexamethasone)
Number of subjects: 142
Study 15538568 — intervention group
Group type: EXPERIMENTAL
Intervention: CEOP/IMVP-Dexa regimen
Number of subjects: 142
Study 12840618 — intervention group
Group type: EXPERIMENTAL
Intervention: Bupivacaine 0.25% with epinephrine (1/200,000)
Number of subjects: 53
Study 12840618 — intervention group
Group type: EXPERIMENTAL
Intervention: Morphine 5 mg
Number of subjects: 53
Study 12840618 — intervention group
Group type: COMPARATOR
Intervention: Saline (placebo)
Number of subjects: 53
Study 10774589 — intervention group
Group type: EXPERIMENTAL
Intervention: Atevirdine (dose-adjusted to achieve plasma trough concentrations of 5-10 microM) and zidovudine (200 mg every 8 h) for 12 weeks (ACTG 199)
Number of subjects: 50
Study 10774589 — intervention group
Group type: EXPERIMENTAL
Intervention: Atevirdine monotherapy with doses adjusted to achieve targeted trough plasma concentration ranges (5-13, 14-22, and 23-31 microM) for 12 weeks (ACTG 187)
Number of subjects: 50
Study 8843126 — intervention group
Group type: EXPERIMENTAL
Intervention: Carboxymethylcellulose (CMC)
Number of subjects: 55
Study 8843126 — intervention group
Group type: COMPARATOR
Intervention: Hydroxypropyl methylcellulose (HPMC)
Number of subjects: 55
Study 1632177 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicardipine
Number of subjects: 0
Study 1632177 — intervention group
Group type: COMPARATOR
Intervention: Sodium nitroprusside
Number of subjects: 0
Study 6743720 — intervention group
Group type: EXPERIMENTAL
Intervention: Naloxone (2 mg/kg iv bolus infusion)
Number of subjects: 14
Study 6743720 — intervention group
Group type: COMPARATOR
Intervention: Placebo infusion
Number of subjects: 14
Study 30684674 — intervention group
Group type: EXPERIMENTAL
Intervention: OFD + aPDT (Indocyanine green dye activated with 810 nm diode laser)
Number of subjects: 20
Study 30684674 — intervention group
Group type: COMPARATOR
Intervention: OFD alone
Number of subjects: 20
Study 29424441 — intervention group
Group type: EXPERIMENTAL
Intervention: 1000 mg IV iron isomaltoside infusion
Number of subjects: 85
Study 29424441 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 85
Study 26710216 — intervention group
Group type: EXPERIMENTAL
Intervention: IV morphine 5 mg (group M)
Number of subjects: 60
Study 26710216 — intervention group
Group type: EXPERIMENTAL
Intervention: Tramadol 100 mg (group T)
Number of subjects: 60
Study 26710216 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketorolac 60 mg (group K)
Number of subjects: 60
Study 24687182 — intervention group
Group type: EXPERIMENTAL
Intervention: ACT & Check Strategy intervention
Number of subjects: 25
Study 24687182 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 25
Study 23026514 — intervention group
Group type: EXPERIMENTAL
Intervention: High thiamine diet (2.8 mg/day)
Number of subjects: 0
Study 23026514 — intervention group
Group type: COMPARATOR
Intervention: Adequate thiamine diet (1.1 mg/day)
Number of subjects: 0
Study 20040884 — intervention group
Group type: EXPERIMENTAL
Intervention: Musculoskeletal therapy and physical therapy prior to weight management program
Number of subjects: 54
Study 20040884 — intervention group
Group type: COMPARATOR
Intervention: Direct entry into the weight management program
Number of subjects: 54
Study 18594319 — intervention group
Group type: EXPERIMENTAL
Intervention: TG4010 combined with cisplatin (100 mg/m day 1) and vinorelbine (25 mg/m day 1 and day 8)
Number of subjects: 65
Study 18594319 — intervention group
Group type: EXPERIMENTAL
Intervention: TG4010 monotherapy until disease progression, followed by TG4010 plus the same chemotherapy as in Arm 1
Number of subjects: 65
Study 16026404 — intervention group
Group type: EXPERIMENTAL
Intervention: Open Burch colposuspension using sutures (OC)
Number of subjects: 211
Study 16026404 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic colposuspension using sutures (LCS)
Number of subjects: 211
Study 16026404 — intervention group
Group type: COMPARATOR
Intervention: Laparoscopic colposuspension using mesh and staples (LCM)
Number of subjects: 211
Study 12422590 — intervention group
Group type: EXPERIMENTAL
Intervention: Azithromycin 20 mg/kg/day for the first day followed by 10 mg/kg/day for a further four days
Number of subjects: 42
Study 12422590 — intervention group
Group type: COMPARATOR
Intervention: Phenoxymethylpenicillin 100,000 IU/kg/day for 14 days
Number of subjects: 42
Study 10028084 — intervention group
Group type: EXPERIMENTAL
Intervention: Clarithromycin plus clofazimine with additional antimycobacterial drugs (ethambutol, ciprofloxacin, amikacin, rifabutin)
Number of subjects: 8
Study 10028084 — intervention group
Group type: COMPARATOR
Intervention: Clarithromycin plus clofazimine
Number of subjects: 8
Study 9014762 — intervention group
Group type: EXPERIMENTAL
Intervention: Tamoxifen (TAM)
Number of subjects: 35
Study 9014762 — intervention group
Group type: COMPARATOR
Intervention: Control (observation alone)
Number of subjects: 35
Study 1666320 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardiovasoprotective diet (group A, n = 228)
Number of subjects: 458
Study 1666320 — intervention group
Group type: COMPARATOR
Intervention: Usual diet (group B, n = 230)
Number of subjects: 458
Study 6616153 — intervention group
Group type: EXPERIMENTAL
Intervention: L-phenylalanine mustard (L-PAM) as adjuvant chemotherapy
Number of subjects: 241
Study 6616153 — intervention group
Group type: EXPERIMENTAL
Intervention: Routine sequential chest radiography
Number of subjects: 241
Study 29617707 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased physical activity
Number of subjects: 692
Study 29617707 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower BMI
Number of subjects: 692
Study 29617707 — intervention group
Group type: EXPERIMENTAL
Intervention: Change in physical activity through BMI change
Number of subjects: 692
Study 29617707 — intervention group
Group type: EXPERIMENTAL
Intervention: BMI below the mean
Number of subjects: 692
Study 26678445 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise therapy and patient education
Number of subjects: 109
Study 26678445 — intervention group
Group type: COMPARATOR
Intervention: Patient education only (control group)
Number of subjects: 109
Study 25683747 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.3 g/kg glucose
Number of subjects: 34
Study 25683747 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.2 g/kg glucose
Number of subjects: 34
Study 25683747 — intervention group
Group type: COMPARATOR
Intervention: 15 g glucose
Number of subjects: 34
Study 24080099 — intervention group
Group type: EXPERIMENTAL
Intervention: GM‐CSF plus supervised treadmill exercise
Number of subjects: 0
Study 24080099 — intervention group
Group type: EXPERIMENTAL
Intervention: GM‐CSF plus attention control
Number of subjects: 0
Study 24080099 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus supervised exercise therapy
Number of subjects: 0
Study 24080099 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus attention control
Number of subjects: 0
Study 20019759 — intervention group
Group type: EXPERIMENTAL
Intervention: FC latanoprost/timolol
Number of subjects: 270
Study 20019759 — intervention group
Group type: COMPARATOR
Intervention: FC dorzolamide/timolol
Number of subjects: 270
Study 17897931 — intervention group
Group type: EXPERIMENTAL
Intervention: Life skills promotion program
Number of subjects: 442
Study 16029398 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral transmucosal ketamine (50 mg)
Number of subjects: 55
Study 16029398 — intervention group
Group type: COMPARATOR
Intervention: Oral midazolam (0.5 mg/kg)
Number of subjects: 55
Study 12505543 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypertension (high blood pressure)
Number of subjects: 301
Study 12505543 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypertensive AD patients
Number of subjects: 301
Study 12505543 — intervention group
Group type: COMPARATOR
Intervention: Non-demented individuals
Number of subjects: 301
Study 12505543 — intervention group
Group type: COMPARATOR
Intervention: AD patients vs non-demented individuals
Number of subjects: 301
Study 12505543 — intervention group
Group type: COMPARATOR
Intervention: Different populations stratified by blood pressure
Number of subjects: 301
Study 12505543 — intervention group
Group type: EXPERIMENTAL
Intervention: Blood pressure and AD relationship
Number of subjects: 301
Study 10508285 — intervention group
Group type: EXPERIMENTAL
Intervention: Gadolinium (Gd)‐chelate contrast agents used in MRI
Number of subjects: 0
Study 8554132 — intervention group
Group type: EXPERIMENTAL
Intervention: Operative closed-suction drainage
Number of subjects: 120
Study 8554132 — intervention group
Group type: COMPARATOR
Intervention: No operative closed-suction drainage
Number of subjects: 120
Study 2068474 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of aztreonam and cloxacillin/oxacillin
Number of subjects: 92
Study 2068474 — intervention group
Group type: COMPARATOR
Intervention: Combination of tobramycin and a cephalosporin
Number of subjects: 92
Study 6683538 — intervention group
Group type: EXPERIMENTAL
Intervention: 1500 mg calcium dobesilate
Number of subjects: 52
Study 6683538 — intervention group
Group type: EXPERIMENTAL
Intervention: 1000 mg calcium dobesilate
Number of subjects: 52
Study 6683538 — intervention group
Group type: EXPERIMENTAL
Intervention: 500 mg calcium dobesilate
Number of subjects: 52
Study 6683538 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 52
Study 30706796 — intervention group
Group type: EXPERIMENTAL
Intervention: μm‐PEA 600 mg twice a day for 1 week
Number of subjects: 22
Study 29980202 — intervention group
Group type: EXPERIMENTAL
Intervention: NEOSORB® Plus
Number of subjects: 100
Study 29980202 — intervention group
Group type: COMPARATOR
Intervention: NEOSORB®
Number of subjects: 100
Study 26190371 — intervention group
Group type: EXPERIMENTAL
Intervention: Lunch is in the Bag program
Number of subjects: 577
Study 23355152 — intervention group
Group type: EXPERIMENTAL
Intervention: EGD-colonoscopy sequence
Number of subjects: 1100
Study 23355152 — intervention group
Group type: COMPARATOR
Intervention: Colonoscopy-EGD sequence
Number of subjects: 1100
Study 23355152 — intervention group
Group type: EXPERIMENTAL
Intervention: Colonoscopy
Number of subjects: 1100
Study 21427273 — intervention group
Group type: EXPERIMENTAL
Intervention: Constraint-induced movement therapy (CIMT)
Number of subjects: 64
Study 21427273 — intervention group
Group type: EXPERIMENTAL
Intervention: Bimanual training (BIM)
Number of subjects: 64
Study 21427273 — intervention group
Group type: COMPARATOR
Intervention: Both interventions
Number of subjects: 64
Study 19477400 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardiac Resynchronization Therapy (CRT)
Number of subjects: 71
Study 19477400 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline measures of mechanical dyssynchrony
Number of subjects: 71
Study 17233232 — intervention group
Group type: EXPERIMENTAL
Intervention: R&S + AaR
Number of subjects: 1202
Study 17233232 — intervention group
Group type: COMPARATOR
Intervention: R&S
Number of subjects: 1202
Study 15566928 — intervention group
Group type: EXPERIMENTAL
Intervention: Carvedilol
Number of subjects: 0
Study 11561312 — intervention group
Group type: EXPERIMENTAL
Intervention: Artificial nitric baths (n = 44, group 1)
Number of subjects: 111
Study 11561312 — intervention group
Group type: EXPERIMENTAL
Intervention: Artificial nitric baths plus bicycle exercise (n = 37, group 2)
Number of subjects: 111
Study 11561312 — intervention group
Group type: COMPARATOR
Intervention: Fresh water baths (n = 30, group 3)
Number of subjects: 111
Study 9761098 — intervention group
Group type: EXPERIMENTAL
Intervention: Double bolus urokinase
Number of subjects: 0
Study 9761098 — intervention group
Group type: COMPARATOR
Intervention: Front-loaded alteplase
Number of subjects: 0
Study 7760988 — intervention group
Group type: EXPERIMENTAL
Intervention: Minaprine (200 mg)
Number of subjects: 67
Study 7760988 — intervention group
Group type: COMPARATOR
Intervention: Imipramine (50, 75, 100 mg)
Number of subjects: 67
Study 2397553 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified Xiao‐Jin Pills (MXJP)
Number of subjects: 72
Study 2397553 — intervention group
Group type: COMPARATOR
Intervention: Control group (no MXJP)
Number of subjects: 72
Study 81155 — intervention group
Group type: EXPERIMENTAL
Intervention: Fenoprofen (200 mg) and paracetamol (500 mg) given 3 to 4 times daily for a period of 4 to 14 days
Number of subjects: 75
Study 81155 — intervention group
Group type: COMPARATOR
Intervention: Dihydrocodeine tartrate (30 mg)
Number of subjects: 75
Study 31432379 — intervention group
Group type: EXPERIMENTAL
Intervention: PAX Good Behavior Game (PAX GBG)
Number of subjects: 708
Study 30833647 — intervention group
Group type: COMPARATOR
Intervention: Capecitabine for 6 months (2500 mg/m2/day for 14 out of 21 days)
Number of subjects: 1306
Study 30833647 — intervention group
Group type: EXPERIMENTAL
Intervention: Capecitabine for 12 months (2500 mg/m2/day for 14 out of 21 days)
Number of subjects: 1306
Study 30833647 — intervention group
Group type: COMPARATOR
Intervention: Capecitabine for 6 months
Number of subjects: 1306
Study 30833647 — intervention group
Group type: EXPERIMENTAL
Intervention: Capecitabine for 12 months
Number of subjects: 1306
Study 25481073 — intervention group
Group type: EXPERIMENTAL
Intervention: rTMS over the right precuneus
Number of subjects: 0
Study 25481073 — intervention group
Group type: COMPARATOR
Intervention: Control condition without rTMS
Number of subjects: 0
Study 25481073 — intervention group
Group type: EXPERIMENTAL
Intervention: rTMS over the left precuneus
Number of subjects: 0
Study 21837551 — intervention group
Group type: EXPERIMENTAL
Intervention: Process Assessment of the Learner (PAL) lesson plans, specifically Lesson Sets 4 and 7, conducted via small groups (3-6 students) twice a week for 12 weeks.
Number of subjects: 138
Study 21837551 — intervention group
Group type: COMPARATOR
Intervention: Business-as-usual conditions (control group)
Number of subjects: 138
Study 21837551 — intervention group
Group type: COMPARATOR
Intervention: Typical group (n=67)
Number of subjects: 138
Study 21689916 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral intervention
Number of subjects: 983
Study 19757877 — intervention group
Group type: EXPERIMENTAL
Intervention: Korean folksongs rated by young Koreans
Number of subjects: 4
Study 19757877 — intervention group
Group type: EXPERIMENTAL
Intervention: Korean folksongs rated by young Americans
Number of subjects: 4
Study 19757877 — intervention group
Group type: EXPERIMENTAL
Intervention: Korean folksongs rated by older Koreans
Number of subjects: 4
Study 19757877 — intervention group
Group type: EXPERIMENTAL
Intervention: Korean folksongs rated by older Americans
Number of subjects: 4
Study 16499758 — intervention group
Group type: EXPERIMENTAL
Intervention: Active DC polarization (20 min, 1 mA)
Number of subjects: 19
Study 16499758 — intervention group
Group type: COMPARATOR
Intervention: Sham treatment
Number of subjects: 19
Study 16499758 — intervention group
Group type: EXPERIMENTAL
Intervention: Active DC polarization
Number of subjects: 19
Study 12949691 — intervention group
Group type: EXPERIMENTAL
Intervention: Proproten-100
Number of subjects: 0
Study 12949691 — intervention group
Group type: COMPARATOR
Intervention: Amitriptyline
Number of subjects: 0
Study 12949691 — intervention group
Group type: COMPARATOR
Intervention: Phenazepam
Number of subjects: 0
Study 10669276 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-invasive ventilation on bilevel positive airway pressure (NIV-2P)
Number of subjects: 96
Study 10669276 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous positive airway pressure (CPAP)
Number of subjects: 96
Study 10669276 — intervention group
Group type: COMPARATOR
Intervention: Incentive spirometry (IS)
Number of subjects: 96
Study 9039714 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous and intermittent use of GTN patches
Number of subjects: 320
Study 9039714 — intervention group
Group type: EXPERIMENTAL
Intervention: Changing to a different transdermal system
Number of subjects: 320
Study 1435283 — intervention group
Group type: EXPERIMENTAL
Intervention: Functional-ecological assessment procedure
Number of subjects: 38
Study 1435283 — intervention group
Group type: COMPARATOR
Intervention: Standardized assessment procedure
Number of subjects: 38
Study 1435283 — intervention group
Group type: COMPARATOR
Intervention: Combined assessment package
Number of subjects: 38
Study 3882216 — intervention group
Group type: EXPERIMENTAL
Intervention: Short-term preoperative radiotherapy (RT-group) with 25 Gy (2500 rad) over 5 days
Number of subjects: 352
Study 3882216 — intervention group
Group type: COMPARATOR
Intervention: Surgical treatment only (S-group)
Number of subjects: 352
Study 31203032 — intervention group
Group type: EXPERIMENTAL
Intervention: Individual- and neighborhood-level environmental factors
Number of subjects: 450
Study 31203032 — intervention group
Group type: EXPERIMENTAL
Intervention: Improved neighborhood-level conditions related to social and physical disorder
Number of subjects: 450
Study 30062982 — intervention group
Group type: EXPERIMENTAL
Intervention: Presence of another person near the handwashing location
Number of subjects: 20
Study 30062982 — intervention group
Group type: EXPERIMENTAL
Intervention: Presence of both child(ren) and adult(s) or just children
Number of subjects: 20
Study 30062982 — intervention group
Group type: COMPARATOR
Intervention: No presence of another person
Number of subjects: 20
Study 26909534 — intervention group
Group type: EXPERIMENTAL
Intervention: HRV-guided experimental training (EXP)
Number of subjects: 40
Study 26909534 — intervention group
Group type: COMPARATOR
Intervention: Traditional predefined training (TRAD)
Number of subjects: 40
Study 24909206 — intervention group
Group type: EXPERIMENTAL
Intervention: Closed-loop therapy with meal announcement
Number of subjects: 12
Study 24909206 — intervention group
Group type: COMPARATOR
Intervention: Conventional pump therapy
Number of subjects: 12
Study 22733953 — intervention group
Group type: EXPERIMENTAL
Intervention: Risedronate treatment from one week after surgery (Group A)
Number of subjects: 90
Study 22733953 — intervention group
Group type: EXPERIMENTAL
Intervention: Risedronate treatment from one month after surgery (Group B)
Number of subjects: 90
Study 22733953 — intervention group
Group type: EXPERIMENTAL
Intervention: Risedronate treatment from three months after surgery (Group C)
Number of subjects: 90
Study 22733953 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific intervention timing mentioned)
Number of subjects: 90
Study 22733953 — intervention group
Group type: EXPERIMENTAL
Intervention: Functional outcomes at one year after surgery
Number of subjects: 90
Study 22733953 — intervention group
Group type: EXPERIMENTAL
Intervention: Incidence of complications
Number of subjects: 90
Study 21203736 — intervention group
Group type: EXPERIMENTAL
Intervention: Presence of impaction (Group 1)
Number of subjects: 83
Study 21203736 — intervention group
Group type: COMPARATOR
Intervention: Absence of impaction (Group 2)
Number of subjects: 83
Study 21203736 — intervention group
Group type: EXPERIMENTAL
Intervention: Mandibular length
Number of subjects: 83
Study 21203736 — intervention group
Group type: EXPERIMENTAL
Intervention: Difference between alveolar arch length and total teeth size
Number of subjects: 83
Study 21203736 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined prediction from both factors
Number of subjects: 83
Study 21203736 — intervention group
Group type: EXPERIMENTAL
Intervention: Body Mass Index (BMI)
Number of subjects: 83
Study 17391167 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin monotherapy
Number of subjects: 57
Study 17391167 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin and metformin up to 2000 mg daily
Number of subjects: 57
Study 17391167 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin and pioglitazone 30 mg daily
Number of subjects: 57
Study 15713724 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral Testosterone (T) 200, 400, or 800 mg in sesame oil
Number of subjects: 13
Study 15713724 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral Testosterone Enanthate (TE) 200, 400, or 800 mg in sesame oil
Number of subjects: 13
Study 15713724 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral Testosterone (T) 200, 400, or 800 mg in sesame oil with Dutasteride (D)
Number of subjects: 13
Study 15713724 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral Testosterone Enanthate (TE) 200, 400, or 800 mg in sesame oil with Dutasteride (D)
Number of subjects: 13
Study 11999596 — intervention group
Group type: EXPERIMENTAL
Intervention: Cisatracurium
Number of subjects: 30
Study 11999596 — intervention group
Group type: COMPARATOR
Intervention: Rocuronium
Number of subjects: 30
Study 9793363 — intervention group
Group type: EXPERIMENTAL
Intervention: Glass-ionomer systems with dental dike and varnish
Number of subjects: 0
Study 9793363 — intervention group
Group type: COMPARATOR
Intervention: Five ionomeric products
Number of subjects: 0
Study 7890497 — intervention group
Group type: EXPERIMENTAL
Intervention: Monocular acuity norms using the acuity card procedure (ACP) and Teller Acuity Cards (TAC)
Number of subjects: 460
Study 7890497 — intervention group
Group type: EXPERIMENTAL
Intervention: Monocular acuity tests
Number of subjects: 460
Study 7890497 — intervention group
Group type: EXPERIMENTAL
Intervention: Interocular acuity difference
Number of subjects: 460
Study 7890497 — intervention group
Group type: EXPERIMENTAL
Intervention: Acuities obtained by the same tester on different days and by different testers on the same day
Number of subjects: 460
Study 2111982 — intervention group
Group type: EXPERIMENTAL
Intervention: OKT3 monoclonal antibody (replacing cyclosporine during the first postoperative week)
Number of subjects: 79
Study 2111982 — intervention group
Group type: COMPARATOR
Intervention: Conventional immunosuppression (cyclosporine, azathioprine, and steroids)
Number of subjects: 79
Study 2111982 — intervention group
Group type: EXPERIMENTAL
Intervention: OKT3 monoclonal antibody
Number of subjects: 79